Diabetic Neuropathy (DN) is often overlooked as a mortality risk and the Diabetic Neuropathy Device (DND) addresses this gap by being the first FDA-cleared, multi-objective, non-invasive tool that measures both large and small nerve fibers in peripheral extremities